Eli Lilly will halve its originally planned investment of €2.3 billion ($2.67 billion) in Germany, CEO Dave Ricks told the Handelsblatt business daily.
Over a billion euros has already been invested in the production site for weight-loss injections in Alzey in the western state of Rhineland-Palatinate, the German business daily reported on Wednesday.
Sign up here.
The high-tech plant is still s… [541 chars]
Source: Reuters | Published: 2026-06-03T16:33:24Z
Credit: Reuters
